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Surface plasmon resonanceSticholysin II (StnII) is a pore-forming toxin from the sea anemone Stichodactyla heliantus which belongs to
the large actinoporin family. The toxin binds to sphingomyelin (SM) containing membranes, and shows
high binding speciﬁcity for this lipid. In this study, we have examined the role of the hydrogen bonding
groups of the SM long-chain base (i.e., the 2NH and the 3OH) for StnII recognition. We prepared methylated
SM-analogs which had reduced hydrogen bonding capability from 2NH and 3OH. Both surface plasmon
resonance experiments, and isothermal titration calorimetry measurements indicated that StnII failed to bind
to bilayers containing methylated SM-analogs, whereas clear binding was seen to SM-containing bilayers.
StnII also failed to induce calcein release (i.e., pore formation) from vesicles made to contain methylated
SM-analogs, but readily induced calcein release from SM-containing vesicles. Molecular modeling of SM docked
to the phosphocholine binding site of StnII indicated that the 2NH and 3OH groups were likely to form a hydro-
gen bond with Tyr135. In addition, it appeared that Tyr111 and Tyr136 could donate hydrogen bonds to phos-
phate oxygen, thus stabilizing SM binding to the toxin. We conclude that the interfacial hydrogen bonding
properties of SM, in addition to the phosphocholine head group, are crucial for high-afﬁnity SM/StnII-interaction.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Sticholysin II (StnII) is a pore-forming single-peptide toxin isolated
from the sea anemone Stichodactyla heliantus [1]. Structurally, it is
highly related to other single peptide toxins in the actinoporin family,
including equinatoxin II (EqtII) [1,2]. The StnII structure is based on a
β-sandwich fold composed of 10 β-strands, with two α-helices inter-
acting with both sides of the β-sandwich [3]. The N-terminal helix is
amphiphilic and has been proposed to extend and be inserted into the
bilayer, to form the pore walls [4,5]. Incorporation of the toxin into
the bilayer depends largely on the composition and physicochemical
state of the membrane [6–8]. A common and functionally important
feature of actinoporins is their high speciﬁcity for sphingomyelin (SM)itration calorimetry; LUV, large
POC, phosphocholine (binding
holine; PSM, palmitoyl SM; SM,
d SM analog used for docking
olysin II
l rights reserved.[9,10], but actinoporin/membrane association is also inﬂuenced by the
physical properties of the bilayer membranes [7,11–13].
StnII binds to SM-containing phospholipid-membranes with high af-
ﬁnity (K=1.7×108 M−1) [11]. Mutation of a tyrosine residue (Y111N)
in the phosphocholine (POC) binding site on StnII was shown by isother-
mal titration calorimetry (ITC) to reduce the bilayer binding constant of
StnII by two orders of magnitude [11]. Since this residue was located in
the POC-binding site, the results suggested that binding to SM was
crucial for the highmembrane afﬁnity of StnII. However, the exact nature
of SM/StnII interaction is not known, since no 3D structure of StnII is
available with bound SM.
The speciﬁcity of actinoporins for SM has been convincingly demon-
strated [10]. However, it appears that under speciﬁc conditions, some
actinoporins may show low-afﬁnity interaction with phosphatidylcho-
lines and cause membrane permeabilization, but only in the presence
of phase coexistence, most probably mediated by cholesterol [7,13,14].
In a dot-blot binding assay, phosphatidylcholine is not recognized by
equinatoxin II, neither is ceramide nor sphingosylphosphorylcholine
[10]. These observations together suggest that both the phosphocholine
head group and the hydrogen bonding interfacial groups in SM (the
2NH and the 3OH) are important for toxin binding. Sphingomyelinase,
which is speciﬁc for SM and does not degrade phosphatidylcholine,
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addition to the phosphocholine head group) of SM to stabilize binding
to the active site [15,16].
In this study, we examine the importance of the 2NH and 3OH in
SM for pore formation by StnII. By chemical synthesis, we have pre-
pared SM analogs in which either the 2NH or the 3OH is methylated
[17], to yield 2NMeSM and 3OMeSM, respectively. We have prepared
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) bilayers
containing either palmitoyl SM (PSM), or one of the methylated PSM
analogs (POPC:SM molar ratio 4:1). With such bilayers, we found that
StnII caused extensive calcein leakage only in PSM-containing bilayers.
With surface plasmon resonance (SPR) analysis, only PSM-containing
vesicles caused StnII binding. Very similar results were shown using
isothermal titration calorimetry (ITC) to study toxin binding to bilayer
membranes. StnII was found to interact only with PSM-containing
vesicles. Finally, using molecular docking of PSM to a 3D model of
StnII, we suggest that Y135 in the POC-binding site stabilized SM bind-
ing by interactions with the 2NH and 3OH of PSM, whereas Y111 and
Y136 formed hydrogen bonds to phosphate oxygen, possibly explaining
the binding speciﬁcity for SM.
2. Materials and methods
2.1. Material
POPC, porcine brain SM (pbSM), and egg SM were obtained from
Avanti Polar Lipids (Alabaster, AL, USA). PSM was puriﬁed from egg
SM using preparative HPLC on a reverse phase (C18) column, as de-
scribed previously [18]. The acyl chains of pbSM are mostly saturated
(50% 18:0 and19% other saturated) while 24:1 is present at 21% (Avanti
Polar Lipids). Methylated analogs of PSM (i.e., 2NMeSM and 3OMeSM)
were prepared by chemical synthesis, as described previously [17].
Calcein and Sephacryl S200HR were obtained from Sigma/Aldrich
(St. Louis, MO, USA). StnII was produced in an E.coli expression system,
and puriﬁed, as described previously [19].
2.2. Calcein leakage assay
Calcein-entrapped large unilamellar vesicles (LUVs) were prepared
from POPC and a SM-analog (4:1 molar ratio), by extrusion through
200 nm ﬁlters at 60 °C [20]. Brieﬂy, the desired lipids were mixed
and dried under a stream of nitrogen. The lipids were redissolved in
chloroform and dried again before removal of any traces of remaining
solvent in vacuum for 60 min. Prior to extrusion, the dry lipid ﬁlms
were hydrated for 30 min at 60 °C in Tris buffer containing calcein.
The calcein concentration was 100 mM (10 mM Tris, 140 mM NaCl,
pH 7.4), and the total lipid concentration was 1.25 mM. LUVs were
separated from non-entrapped calcein by gel ﬁltration on Sephacryl
S200HR. The LUVs were used for permeabilization studies within 24 h.
The concentration of LUV and StnII during calcein leakage experiments
was 2.5 μMand 20 nM, respectively. Emission at 550 nmwas followed
at 23 °C as a function of time (Ex 480 nm). Fluorescence emission was
measured on a PTI Quanta-Master spectroﬂuorimeter (Photon Tech-
nology International, Inc. NJ, USA). The released fraction of calcein
was determined based on the maximum calcein release which was
induced by Triton X-100 induced LUV disintegration. To ensure that
no spontaneous leakage occurred, the emission was measured for each
sample for 5 min before addition of toxin. A steady signal level, indicat-
ing intact vesicles, was observed for all samples.
2.3. Surface plasmon resonance spectroscopy
The association of StnII with vesicle-coated gold chips were
performed as follows: LUVs were prepared from POPC or POPC/SM
analog (4:1, molar ratio) in Tris buffer (10 mM Tris, 140 mM NaCl,
pH 7.4) by extrusion through 100 nm polycarbonate ﬁlters at 60 °C.StnII binding to the vesicles was studied at 23 °C with a BioNavis
SPR Navi 200 instrument (BioNavis Ltd, Tampere, Finland). The
sensor gold chip was coated with a carboxymethylated dextran
layer which was treated with N-hydroxysuccinimide and N-ethyl-N′
(dimethylaminopropyl) carbodiimide to activate the surface for
capturing phospholipid membranes [21]. All solutions used for SPR
were ﬁltered through 0.2 μm membrane ﬁlters and degassed by bath
sonication before use. The running buffer was 10 mM Tris, 140 mM
NaCl, pH 7.4 and the ﬂow rate was 5 μl/min. First, the chip surface was
cleaned with two injections of 10 mM CHAPS. Then extruded LUVs
(0.5 mM lipid concentration) were applied on the surface (12 min
injection) and unbound vesicleswere removed by one (3 min) injection
of 50 mM NaOH. Bovine serum albumin (0.1 mg/ml, 3 min injection)
was used to verify that the chip did not have uncovered areas. Finally
StnII (1.0 μM) was applied for 22–24 min after which buffer alone
was injected for 10 min to study toxin dissociation. The chip was
regenerated with CHAPS as in the beginning of the experiment.
2.4. Isothermal titration calorimetry
The interaction between StnII and LUVs prepared from POPC and
SM analogs (4:1 molar ratio, 100 nm diameter) was measured using
a VP-ITC (MicroCal, Northampton, MA, USA), as described previously
[11].
2.5. Computational studies
The structure of SM was sketched and energy minimized in
SYBYL-X2.0 (Tripos, St. Louis, MO, USA) using the conjugate gradient
method with MMFF94s charges [22] and a dielectric constant of 10.
The termination gradient was set to 0.05 kcal/mol, and calculations
were iterated until convergence was reached. PSM was drawn with
two different conﬁgurations: PSM and a shortened version composed
of the phosphocholine part, the long-chain base until C5, and the
N-linked acyl chain until the Cα (sSM).
The 3D structure of StnII (PDB: 1O72 [3]) was acquired from the
Protein Data Bank [23]. Hydrogen atoms were added into the StnII
structure using TLEAP in ANTECHAMBER 1.27 [24]. The docking of
PSM to the phosphocholine binding site of StnII was performed ﬂex-
ibly with GOLD 5.0 [25] using ChemScore scoring function, diverse
solutions option, and the most accurate (slow) docking. Docking atom
selection was not restricted entirely to the solvent-accessible surface.
Both PSM and the sSM were used in docking experiments. However,
due to the conformational space that the docking should cover for
PSM, and since the main focus was on the exploring of the interfacial
portion of the SM, the docking of sSM was studied more thoroughly.
In addition, the stability of the ligand-protein complex was studied
with molecular dynamics (MD) simulations. MD simulations were
done as described previously [16]. Multiple starting conformations of
PSM (obtained via molecular docking) were used in the MD.
3. Results
3.1. StnII pore formation and membrane binding
The importance of speciﬁc functional groups in SM structure for
StnII binding to bilayers, and for subsequent pore formation, was
examined using chemically synthesized SM analogs in which either
the 2NH or the 3OH was methylated (see Scheme 1 for molecular
structures). The methylated SM analogs have markedly reduced capa-
bility to form hydrogen bonds compared to unmodiﬁed SM [17].
StnII binding to SM-rich bilayers is known to lead to pore for-
mation, and to membrane permeabilization for small solutes. We
measured calcein leakage from LUVs which were prepared to contain
POPC and one of the SM analogs (4:1 molar ratio; Fig. 1). While PSM-
containing membranes were permeabilized efﬁciently by StnII, both
Scheme 1. Molecular structures of the three SM analogs used in the study: (1) palmitoyl
SM, (2) 2NMe palmitoyl SM, and (3) 3OMe palmitoyl SM.
Fig. 2. SPR sensogram showing the binding of StnII to immobilized vesicles of different
lipid composition. The vesicles consisted of 1: POPC, 2: POPC/PSM (4:1), 3: POPC/NMe-SM
(4:1) or 4: POPC/OMe-SM (4:1). Vesicles (0.5 mM total lipid) were ﬁrst immobilized on
the chip surface for 12 min. Then StnII (1.0 μM) was allowed to bind for 22–24 min
(starting at 0 s). The arrows indicate the injection of buffer (10 mM Tris, 140 mM NaCl,
pH 7.4) to study toxin dissociation. The ﬂow rate was 5 μl/min and the temperature was
23 °C. The ﬁgure shows representatives of at least 3 independent experiments.
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The leakage from POPC LUVs was also very slow under the conditions
used (Fig. 1).
Since calcein leakage only indicates pore formation, but gives no
information about StnII binding to vesicles per se, we next used SPR
to examine StnII binding to gold chips coated with different vesicles
containing POPC and PSM or one of the methylated PSM analogs
(Fig. 2). The SPR sensogram showed efﬁcient binding of StnII to bilayers
containing PSM, but not to bilayers containingmethylated PSM, or POPC
alone. The off-rate of StnII from PSM-containing bilayers was also negli-
gible, indicating high afﬁnity binding. The small initial deviations in the
SPR response after injection of StnII could relate tomismatch in solvents
(vesicle loading solvent versus StnII-containing solvent).Fig. 1. The StnII-induced release of calcein from LUVs containing POPC and SM analogs
was examined at 23 °C. The LUVs contained POPC and SM in a 4:1 molar ratio. StnII was
added to the sample cell at time zero, and the RF (%) was calculated at time points
indicated. Each value is the average from 3 to 5 separate experiments±SD.In order to study direct toxin/bilayer binding with another method,
we measured StnII/vesicle interaction by using ITC, which in addition
also gives thermodynamic data for the binding process. The heat released
after injection of POPC bilayers to StnII was close to zero (Fig. 3), indicat-
ing no substantial binding of StnII to POPC. Inclusion of PSM in the POPC
bilayers resulted in clear exothermic signals when StnII was added.
The calculated K for StnII binding to POPC/PSM (4:1 molar ratio) was
1.80×106 M−1 (Table 1). A very similar result (K=1.44×106 M−1,
Table 1) was obtained when using pbSM containing vesicles. pbSM has
a very different composition from PSM in terms of fatty acids composi-
tion (see Section 2). With methylated PSM analogs in the POPC vesicles,
StnII failed to interact with the bilayers, since the interaction energy was
close to zero (Fig. 3).
3.2. Computational studies of sphingomyelin binding to sticholysin II
To deduce the structural details that are important for SM recogni-
tion by StnII, and to outline the binding interactions of SM with StnII,
SMwas docked to the POC binding site of StnII. Overall, the docking pose
of the phosphocholine moiety of SM is relatively similar to the pose
appeared in the StnII crystal structure complexed with phosphocholine
(PDB:1O72 [3]). sSMwas used in the initial docking experiments, because
interactions of the toxin with the phosphocholine moiety and with both
2NH and 3OH are likely to be important for SM recognition. Additionally,
there are no clear grooves on the surface of the toxin for the hydrocarbon
chains, and thus, the chains are not supposed to interact with the binding
site of StnII, as suggested before [10].
The ligand binding cavity of StnII contains a cluster of aromatic
amino acids, and is partly hydrophobic and partly hydrophilic. For
example side chains of Val85, Pro105, and Trp114, and aromatic rings
of several tyrosine residues (Tyr111, Tyr131, Tyr135, and Tyr136) are
hydrophobic, whereas side chains of Ser52, and Ser103, and phenolic
hydroxyl groups of the above-mentioned tyrosine residues add hydro-
philic properties to the binding site [3]. Docking results suggested that
the 2NH and 3OH groups of SMdonate a hydrogen bond to the phenolic
hydroxyl group of Tyr135 (Fig. 4). Furthermore, Tyr111 and Tyr136
could form hydrogen bonds to the oxygen atoms of the phosphate
moiety through the phenolic hydroxyl groups (Fig. 4). Additionally,
the phosphate moiety could be further stabilized by the cationic side
chain of Arg51. Throughout the MD simulation, the phosphocholine
moiety of PSM remains similarly bound into the ligand binding site.
However, the long hydrocarbon chains do not ﬁnd stable conformation
but remain ﬂexible as there are no grooves on the surface of the protein
Fig. 3. Binding of StnII to POPC/SM analog vesicles at 25 °C. Protein solutions at 10 μM were titrated by injection of 20 μL aliquots of lipid suspensions (5 mM). Binding isotherms
were adjusted to a model were the protein binds the membrane involving n lipid molecules [11].
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with the pbSM ITC resultswhich indicate that the fatty acid chain length
is not important for binding (Table 1).
4. Discussion
Sphingomyelins are important phospholipids in animal cell mem-
branes [26]. They often have saturated ormonounsaturated acyl chains,
and are thus ordered lipids [26,27]. Their ordered nature, and their
extensive hydrogen bonding properties help to form SM-rich ordered
domains in cell membranes [28]. Cholesterol associates with SM-rich
domains and helps to keep them in a liquid ordered state [29]. In addi-
tion to maintaining membrane structure, and serving as precursors
for many bioactive sphingolipids [30], SMs are also used by extracel-
lular proteins as “receptors” to which they may bind [31]. This is also
evidenced by the toxins from the actinoporin family, which are known
to lyse membranes which contain SM [1,2,8,32,33].
The lipid speciﬁcity of equinatoxin II (EqtII) binding has been shown
to be very high, since only SM is recognized by the toxin, from a range
of other sphingolipids or glycerophospholipids [10]. However, EqtII is
known to penetrate into monolayers from both SM and phosphati-
dylcholine, if the initial surface pressure is below 25–26 mN/m [14].
The toxin was also shown to cause bilayer permeabilization in vesicles
made from cholesterol and phosphatidylcholine [7,14]. It appears that
while binding of SM to StnII is of high afﬁnity, phosphatidylcholine
can bind to StnII but with much less afﬁnity, and somehow cholesterol
appears to facilitate this at least in in vitro studies.
All the results in this study clearly show that StnII failed to interact
with or cause pore formationwith bilayers which contained SM analogs
in which the 2NH and 3OH functional properties were compromised.
It therefore appears that these two functional groups are important
for giving speciﬁcity and high afﬁnity for StnII/membrane interaction
and for pore formation. Methylation of the 2NH of SM was recentlyTable 1
Isothermal titration calorimetric analysis of the binding of StnII to POPC:PSM or POPC:









POPC:PSM 48±1 1.80±0.32 −6.4±0.8 −29.3±1.5 −77±7
POPC:SM 45±1 1.44±0.22 −6.3±0.5 −25.4±1.1 −64±6
Values are the mean of at least two independent determinations (±SEM). Binding
isotherms were adjusted to a model were the protein binds the membrane involving
n lipid molecules [11].shown to reduce its gel-phase stability [17], suggesting that hydrogen-
bonding involving the 2NH are important for SM–SM interlipid inter-
actions. The 3OMe analog also showed slightly decreased gel-phase
stability, but much less than for 2NMe. Sterol afﬁnity for bilayers
containing the methylated SM analogs was markedly lowered com-
pared to PSM.
The 2NH and 3OH in SM have in many studies been shown to be of
critical importance for the biophysical membrane properties of SM
[17,34], and for the speciﬁcity of sphingomyelinase for SM [15,16].
The amino acid residues in the phospholipid binding site of StnII (or
EqtII), which are most likely to give speciﬁcity for SM, are Tyr 111
(Tyr 113 in EqtII) and Trp 110 (Trp 112 in EqtII). Replacing Trp112
in EqtII with more polar residues led to loss of pore formation in
DOPC:SM bilayers (as deduced from membrane permeabilization)
[10,35]. Conversion of Tyr113 in EqtII to Ala113 also led to loss of
pore formation in DOPC:SM bilayers, but Tyr113 could be convertedFig. 4. Molecular docking of SM to the POC binding site of StnII. The protein structure
(PDB: 1O72 [3]) is shown with secondary structure in gray whereas SM and key
amino acids are shown in stick models. Hydrogen bonds are indicated with purple
dashed lines. The 2NH and 3OH groups form a hydrogen bond with Tyr135. Additionally,
Tyr111 and Tyr136 donate hydrogen bonds to the phosphate group. The ﬁgure was
prepared using BODIL [36], MOLSCRIPT v 2.1.2 [37], and the RASTER3D package [38].
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formation [10]. In StnII, mutation of Tyr111 to Asn111 signiﬁcantly
reduced hemolytic activity of the toxin. This mutation also led to a 2
orders of magnitude less membrane afﬁnity, compared to the wild
type StnII [11].
Our SMdockingmodel suggests that the phosphate oxygens interact
with Tyr111 and Tyr136, while the 2NH and 3OH engage in electrostatic
interactions with Tyr135. Additionally, the phosphate moiety could be
further stabilized by the cationic side chain of Arg51. Methylation of
2NH and 3OH would prevent such interactions. Also MD simulations
support the stable positioning of the phosphocholine head group of
the SM into the ligand binding site.
It remains unclear what contribution, if any, the steric size (and
hydrophobicity) of the methyl group would impose on SM/POC
binding site interactions. However, in the case where these methyl-
ated SM analogs were allowed to interact with the binding site of
sphingomyelinase, it was reasoned that attenuated hydrogen bond-
ing was a more important factor than the steric size of the methyl,
to eliminate their substrate capability [15,16]. This model does not
contradict results from mutation studies involving Tyr111 (or Trp112
and Tyr113 in EqtII). It suggests, however, that mutation studies in
which Tyr135 and Tyr136 would be changed, would be worthwhile to
undertake, in order to better clarify the role of these residues for stabi-
lizing SM/toxin interaction in the POC site.
The results of this study do not directly address questions related to
the role of 2NH or 3OH in the SM structure for (i) membrane binding of
StnII, and (ii) for the subsequent oligomerization and pore formation.
However, the lack of apparent membrane binding of the methylated
SM analogs (SPR and ITC data, Figs. 2 and 3), and the failure to cause
signiﬁcant membrane permeabilization (Fig. 1), suggest that the meth-
ylated SM analogs failed to support stable membrane association of
StnII. This would conﬁrm that high afﬁnity interaction between StnII
and SM is required for stable membrane association of StnII. The slow
kinetics (relatively speaking) of both membrane permeabilization
(calcein leakage) and membrane association (SPR sensogram) suggest
that pore formation (i.e., oligomerization) is rate limiting relative to
membrane association.
This study is the ﬁrst to have used SM analogs with compromised
hydrogen bonding properties, in the characterization of SM/StnII
interaction. With the help of mutational studies with actinoporin
toxins, the amino acid residues important for SM recognition have
been identiﬁed. Our results with the methylated SM analogs comple-
ment the current understanding of SM/toxin interaction, and provide
further evidence for the mechanisms involved in the high afﬁnity
binding of StnII to SMs.
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